Oncology Pharma Inc. (OTCMKTS:ONPH – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $0.04 and traded as high as $0.0405. Oncology Pharma shares last traded at $0.0405, with a volume of 9,604 shares.
Oncology Pharma Trading Down 8.6%
The company has a fifty day moving average of $0.04 and a 200 day moving average of $0.05.
About Oncology Pharma
Oncology Pharma, Inc. is a biopharmaceutical company focused on developing treatments for cancer. Its business centers on oncology drug development rather than a portfolio of marketed medicines. The company has worked on Nano-Cycl, an investigational nanoparticle-based formulation involving cyclodextrin for potential use in cancer treatment. The candidate remains a development effort, not an established commercial product. Publicly available information about Oncology Pharma’s leadership, operating history and geographic reach is limited, so those details are not included here.
Further Reading
- Five stocks we like better than Oncology Pharma
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for Oncology Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
